Robert K. Zeldin - Concepedia

Author

Robert K. Zeldin

Also Known As

Michel Roux, R ZELDIN, R Zeldin, R. K. Zeldin, R. Zeldin, R.-K. Zeldin, R.K. Zeldin, Robert K Zeldin, Robert K. Zeldin, Robert Zeldin

100

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Stallergenes Greer (France)University of Colorado Denver Charité - Universitätsmedizin Berlin Novartis (United States)University of Toronto

About

Robert K. Zeldin is an author at Stallergenes Greer (France) specializing in medicine, allergy medicine, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Allergy	9	9	831
3	Allergy Medicine	9	9	831
4	Public Health	3	3	110
5	Social Sciences	1	1	20

Robert K. Zeldin

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura Marie Scully, Spero R. Cataland, Flora Peyvandi, New England Journal of Medicine	2019	956
Treatment of chronic autoimmune urticaria with omalizumab Allen P. Kaplan, Kusumam Joseph, Robert Maykut, Journal of Allergy and Clinical Immunology Autoimmune DiseaseChronic Autoimmune UrticariaClinical DermatologyAutoimmunityDermatology	2008	283
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma Marc Massanari, Harold S. Nelson, Thomas B. Casale, Journal of Allergy and Clinical Immunology AsthmaAllergySpecific ImmunotherapyAllergy MedicineImmunology	2010	223
Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis Karl‐Christian Bergmann, Pascal Demoly, Margitta Worm, Journal of Allergy and Clinical Immunology AsthmaEnvironmental AllergyAllergyAllergy MedicinePeanut Allergy	2014	203
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: The importance of allergen-specific serum IgE Linda Cox, Thomas B. Casale, Anjuli Nayak, Journal of Allergy and Clinical Immunology AsthmaAllergen-specific Serum IgeUs StudyAutoimmune DiseaseAllergy	2012	131
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga, Journal of Thrombosis and Haemostasis	2017	131
The Effect of a Losartan‐Based Treatment Regimen on Isolated Systolic Hypertension William C. Cushman, William E. Brady, Lisa P. Gazdick, Journal of Clinical Hypertension	2002	130
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma Marc Massanari, S.T. Holgate, William W. Busse, Respiratory Medicine AsthmaAllergyAllergy MedicineImmunologyOral Immunotherapy	2009	129
Post‐treatment efficacy of discontinuous treatment with 300IR 5‐grass pollen sublingual tablet in adults with grass pollen‐induced allergic rhinoconjunctivitis A. Didier, H.‐J. Malling, Margitta Worm, Clinical & Experimental Allergy	2013	96
Automated Telecommunication to Obtain Longitudinal Follow-up in a Multicenter Cross-sectional COPD Study Jeffrey Stewart, Sarah Moyle, Gerard J. Criner, COPD Journal of Chronic Obstructive Pulmonary Disease	2012	62

Page 1